Abstract:Summary Background Research in healthy young adults shows that characteristic patterns of brain activity define individual "brain-fingerprints" that are unique to each person. However, variability in these brain-fingerprints increases in individuals with neurological conditions, challenging the clinical relevance and potential impact of the approach. Our study shows that brain-fingerprints derived from neurophysiological brain activity are associated with pathophysiological and clinical traits of individual patients with Parkinson's disease (PD). Methods We created brain-fingerprints from task-free brain activity recorded through magnetoencephalography in 79 PD patients and compared them with those from two independent samples of age-matched healthy controls (N = 424 total). We decomposed brain activity into arrhythmic and rhythmic components, defining distinct brain-fingerprints for each type from recording durations of up to 4 min and as short as 30 s. Findings The arrhythmic spectral components of cortical activity in patients with Parkinson's disease are more variable over short periods, challenging the definition of a reliable brain-fingerprint. However, by isolating the rhythmic components of cortical activity, we derived brain-fingerprints that distinguished between patients and healthy controls with about 90% accuracy. The most prominent cortical features of the resulting Parkinson's brain-fingerprint are mapped to polyrhythmic activity in unimodal sensorimotor regions. Leveraging these features, we also demonstrate that Parkinson's symptom laterality can be decoded directly from cortical neurophysiological activity. Furthermore, our study reveals that the cortical topography of the Parkinson's brain-fingerprint aligns with that of neurotransmitter systems affected by the disease's pathophysiology. Interpretation The increased moment-to-moment variability of arrhythmic brain-fingerprints challenges patient differentiation and explains previously published results. We outline patient-specific rhythmic brain signaling features that provide insights into both the neurophysiological signature and symptom laterality of Parkinson's disease. Thus, the proposed definition of a rhythmic brain-fingerprint of Parkinson's disease may contribute to novel, refined approaches to patient stratification. Symmetrically, we discuss how rhythmic brain-fingerprints may contribute to the improved identification and testing of therapeutic neurostimulation targets. Funding Data collection and sharing for this project was provided by the Quebec Parkinson Network (QPN), the Pre-symptomatic Evaluation of Novel or Experimental Treatments for Alzheimer's Disease (PREVENT-AD; release 6.0) program, the Cambridge Centre for Aging Neuroscience (Cam-CAN), and the Open MEG Archives (OMEGA). The QPN is funded by a grant from Fonds de Recherche du Québec - Santé (FRQS). PREVENT-AD was launched in 2011 as a $13.5 million, 7-year public-private partnership using funds provided by McGill University , the FRQS, an unrestricted research grant from Pfizer Canada , the Levesque Foundation , the Douglas Hospital Research Centre and Foundation , the Government of Canada , and the Canada Fund for Innovation . The Brainstorm project is supported by funding to SB from the NIH ( R01-EB026299-05 ). Further funding to SB for this study included a Discovery grant from the Natural Sciences and Engineering Research Council of Canada of Canada ( 436355-13 ), and the CIHR Canada research Chair in Neural Dynamics of Brain Systems ( CRC-2017-00311 ).

Neurophysiological Biomarkers Parkinson's

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.

Simple biomarkers to distinguish Parkinson's disease from its mimics in clinical practice: a comprehensive review and future directions

Identification of an early-stage Parkinson’s disease neuromarker using event-related potentials, brain network analytics and machine-learning

Molecular Features of Parkinson's Disease in Patient‐Derived Midbrain Dopaminergic Neurons

Resting-state EEG measures cognitive impairment in Parkinson’s disease

Evaluation of Parkinsons disease with early diagnosis using single-channel EEG features and auditory cognitive assessment

Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting

Study of EEG microstates in Parkinson's disease: a potential biomarker?

The neurophysiological brain-fingerprint of Parkinson's disease

Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis

Early diagnosis of Parkinson’s disease using EEG, machine learning and partial directed coherence

Parkinsons Disease Detection via Resting-State Electroencephalography Using Signal Processing and Machine Learning Techniques

Changes in sensorimotor network dynamics in resting-state recordings in Parkinson’s Disease

Individual cases of Parkinson's disease can be robustly classified by cortical oscillatory activity from magnetoencephalography

Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts

Beta–Gamma Phase-Amplitude Coupling as a Non-Invasive Biomarker for Parkinson's Disease: Insights from Electroencephalography Studies

Non-linear dynamical analysis of EEG time series distinguishes patients with Parkinson's disease from healthy individuals

Abnormally low sensorimotor alpha band nonlinearity serves as an effective EEG biomarker of Parkinson's Disease

EEG-Based Mapping of Resting-State Functional Brain Networks in Patients with Parkinson’s Disease

Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes